CL
ALDX icon

CSS LLC’s Aldeyra Therapeutics ALDX Stock Holding History

CSS LLC’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66,100
Closed -$353K – 937
2022
Q3 		$353K Sell
66,100
-46,900
-42% -$281K 0.02% 612
2022
Q2 		$451K Buy
113,000
+83,000
+277% +$285K 0.02% 602
2022
Q1 		$133K Buy
30,000
+4,500
+18% +$17.9K ﹤0.01% 903
2021
Q4 		$102K Buy
+25,500
New +$194K ﹤0.01% 1009
2021
Q3 		– Sell
-90,900
Closed -$1.03M – 1171
2021
Q2 		$1.03M Buy
90,900
+89,100
+4,950% +$1.07M 0.04% 397
2021
Q1 		$21K Buy
+1,800
New +$20.7K ﹤0.01% 890

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CSS LLC's ALDX Position: Q4 2022 in Review

CSS LLC sold out of Aldeyra Therapeutics (ALDX) in Q4 2022, closing a stake of 26,828 shares — an estimated $143K sold.

CSS LLC first reported a position in ALDX in Q1 2021 and held it in 5 quarters. The position peaked at $388K in Q1 2021. 96 funds tracked by Wall St. Rank hold ALDX as of Q4 2022.

  • CSS LLC reported no remaining Aldeyra Therapeutics position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 26,828 Aldeyra Therapeutics shares in Q4 2022, an estimated $143K.
  • CSS LLC first reported a position in Aldeyra Therapeutics in Q1 2021 and held it in 5 quarters.
  • CSS LLC's Aldeyra Therapeutics position peaked at $388K in Q1 2021.
  • 96 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.